See more : Alcon Inc. (ALC.SW) Income Statement Analysis – Financial Results
Complete financial analysis of California Software Company Limited (CALSOFT.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of California Software Company Limited, a leading company in the Software – Application industry within the Technology sector.
- Evolve Transition Infrastructure LP (SNMP) Income Statement Analysis – Financial Results
- Japan Best Rescue System Co.,Ltd. (2453.T) Income Statement Analysis – Financial Results
- Muromachi Chemicals Inc. (4885.T) Income Statement Analysis – Financial Results
- The Platinum Group Public Company Limited (PLAT.BK) Income Statement Analysis – Financial Results
- Gogia Capital Services Limited (GOGIACAP.BO) Income Statement Analysis – Financial Results
California Software Company Limited (CALSOFT.NS)
About California Software Company Limited
California Software Company Limited provides software development, business process outsourcing, and IT infrastructure services. It offers web, mobile, and IoT applications development services; UI-UX designing services; design and development solutions for point of sale platforms; and digital marketing solutions to enhance online presence and drive traffic sales to online businesses, including search engine optimization, app store optimization, social media marketing, and PPC campaign services. The company provides dSPEEDUp eCom, a digital commerce platform for B2B, B2C, and C2C ecommerce businesses; dINSPIRA PoS, a point of sale system for small retail businesses; dBOT, a conversational platform; and dULTIMA Omnichannel platfrom that provides an optimized and seamless consumer experience. It also offers CS- CTMS, a cloud based, configurable, and end-to-end clinical trials management system to manage various aspects of clinical trials; CS-eTrial, a configurable electronic trial master and remote monitoring platform in an electronic format to organize, store, verify, and review documents, images, and other digital content of clinical trials; CS-SAFETY, a cloud based and regulatory compliant end-to-end pharmacovigilance/drug safety system; CS-CLIDAC, a clinical data warehouse and analytics console; and CS- RMS, a clinical trial remote monitoring system. The company was incorporated in 1992 and is based in Chennai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42.80M | 27.64M | 108.57M | 9.00M | 11.75M | 14.50M | 9.53M | 0.00 | 0.00 | 0.00 | 46.36M | 433.59M | 741.75M | 1.77B | 1.97B | 2.59B | 2.35B |
| Cost of Revenue | 18.33M | 10.06M | 13.43M | 4.01M | 3.57M | 2.21M | 3.77M | 1.24M | 4.41M | 3.19M | 82.85M | 297.65M | 0.00 | 376.83M | 286.13M | 505.92M | 420.53M |
| Gross Profit | 24.47M | 17.58M | 95.14M | 4.99M | 8.18M | 12.29M | 5.76M | -1.24M | -4.41M | -3.19M | -36.49M | 135.94M | 741.75M | 1.40B | 1.69B | 2.08B | 1.93B |
| Gross Profit Ratio | 57.18% | 63.61% | 87.63% | 55.42% | 69.62% | 84.73% | 60.42% | 0.00% | 0.00% | 0.00% | -78.71% | 31.35% | 100.00% | 78.75% | 85.51% | 80.44% | 82.07% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.48M | 1.07M | 2.37M | 680.95K | 770.51K | 1.63M | 5.02M | 4.22M | 4.64M | 0.00 | 33.19M | 72.69M | 0.00 | 362.54M | 298.43M | 561.03M | 353.46M |
| Selling & Marketing | 34.00K | 814.56K | 669.91K | 55.49K | 55.72K | 15.86K | 8.40K | 0.00 | 0.00 | 0.00 | 1.54M | 22.03M | 0.00 | 36.68M | 42.37M | 99.42M | 67.99M |
| SG&A | 2.52M | 1.88M | 3.04M | 736.44K | 826.23K | 1.65M | 5.03M | 4.22M | 4.64M | 58.73M | 51.16M | 195.37M | 0.00 | 399.22M | 340.80M | 660.45M | 421.45M |
| Other Expenses | 0.00 | -3.50K | 1.00K | 9.83M | 6.75M | 6.21M | 1.68M | 154.98K | 30.60M | 30.50M | 23.82M | 39.82M | 33.49M | 21.67M | 21.01M | 4.43M | 20.57K |
| Operating Expenses | 2.52M | 14.59M | 32.00M | 10.57M | 7.58M | 7.86M | 6.71M | 6.19M | -419.94M | 81.00M | 182.22M | 555.38M | 1.07B | 1.66B | 1.65B | 2.32B | 1.74B |
| Cost & Expenses | 20.85M | 24.65M | 45.43M | 10.57M | 7.58M | 7.86M | 6.71M | 6.19M | -419.94M | 81.00M | 182.22M | 555.38M | 1.07B | 2.04B | 1.94B | 2.83B | 2.16B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 85.98K | 1.98M | 9.18M | 12.68M | 803.99K | 4.10M | 20.28M | 23.83M |
| Interest Expense | 0.00 | 7.05K | 1.22K | 6.50K | 2.22K | 1.21K | 6.97K | 0.00 | 69.94M | 90.13M | 96.26M | 84.45M | 92.56M | 97.09M | 109.95M | 77.24M | 12.95M |
| Depreciation & Amortization | 7.16M | 8.97M | 11.13M | 2.96M | 831.40K | -6.64M | -5.36M | -17.30M | 3.53M | 30.45M | 68.98M | 44.00M | 695.21M | 48.09M | 48.26M | 67.57M | 29.10M |
| EBITDA | 15.65M | 11.96M | 74.28M | 5.59M | 4.17M | -76.67K | 0.00 | 178.93K | 58.26M | -35.23M | -23.08M | 4.90M | 16.63M | -197.63M | 87.83M | -145.03M | 224.68M |
| EBITDA Ratio | 36.57% | 43.25% | 68.41% | 21.94% | 78.02% | 92.16% | 29.46% | 0.00% | 0.00% | 0.00% | -88.63% | 1.13% | 54.71% | -11.14% | -28.48% | -4.86% | 8.96% |
| Operating Income | 21.96M | 2.99M | 63.14M | 3.39M | -831.40K | 6.64M | 2.81M | 17.30M | 419.94M | -81.00M | -170.09M | -26.95M | -771.13M | -353.23M | 599.79M | -250.94M | 212.04M |
| Operating Income Ratio | 51.30% | 10.81% | 58.16% | 37.70% | -7.08% | 45.79% | 29.46% | 0.00% | 0.00% | 0.00% | -366.91% | -6.22% | -103.96% | -19.92% | 30.38% | -9.70% | 9.04% |
| Total Other Income/Expenses | -13.46M | -12.08M | -29.41M | -772.59K | -1.19M | -6.72M | 2.54M | 37.25M | -431.64M | -69.99M | -56.64M | 0.00 | -438.20M | -17.47M | 584.90M | 0.00 | 0.00 |
| Income Before Tax | 8.49M | 2.99M | 63.14M | -2.92M | 852.47K | -77.88K | 5.36M | 17.47M | -11.74M | -151.00M | -144.29M | -26.95M | -771.13M | -353.23M | 599.79M | -250.94M | 212.04M |
| Income Before Tax Ratio | 19.84% | 10.81% | 58.15% | -32.48% | 7.26% | -0.54% | 56.25% | 0.00% | 0.00% | 0.00% | -311.26% | -6.22% | -103.96% | -19.92% | 30.38% | -9.70% | 9.04% |
| Income Tax Expense | 2.26M | 777.00K | 19.72M | -760.00K | 221.81K | 1.99M | 1.00M | 23.49M | 0.00 | 30.59M | 475.36K | 580.91K | -20.35M | -161.81M | 242.96M | -23.58M | 57.33M |
| Net Income | 6.24M | 2.21M | 45.52M | -2.16M | 630.66K | -2.07M | 4.36M | 17.47M | -11.74M | -151.00M | -144.76M | -27.54M | -775.49M | -191.42M | 356.83M | -227.36M | 154.70M |
| Net Income Ratio | 14.57% | 8.00% | 41.93% | -24.03% | 5.37% | -14.26% | 45.76% | 0.00% | 0.00% | 0.00% | -312.28% | -6.35% | -104.55% | -10.79% | 18.07% | -8.79% | 6.60% |
| EPS | 0.40 | 0.14 | 2.95 | -0.14 | 0.05 | -0.17 | 0.35 | 1.41 | -0.95 | -12.21 | -11.71 | -2.23 | -62.72 | -15.48 | 28.86 | -18.39 | 13.94 |
| EPS Diluted | 0.40 | 0.14 | 2.95 | -0.14 | 0.05 | -0.17 | 0.35 | 1.41 | -0.95 | -12.21 | -11.71 | -2.23 | -62.72 | -15.48 | -18.39 | -18.39 | 13.94 |
| Weighted Avg Shares Out | 15.59M | 15.46M | 15.46M | 15.46M | 12.37M | 12.16M | 12.37M | 12.37M | 12.36M | 12.37M | 12.36M | 12.35M | 12.37M | 12.37M | 12.37M | 12.37M | 11.10M |
| Weighted Avg Shares Out (Dil) | 15.46M | 15.46M | 15.46M | 15.46M | 12.37M | 12.37M | 12.37M | 12.39M | 12.37M | 12.37M | 12.37M | 12.37M | 12.37M | 12.37M | 12.37M | 12.37M | 11.10M |
Source: https://incomestatements.info
Category: Stock Reports